Please login to the form below

Not currently logged in
Email:
Password:

Former FDA adviser joins Precision for Medicine

Vicki Seyfert-Margolis appointed chief of science and strategy at life science research company

Precision for Medicine Vicki Seyfert-Margolis Precision for Medicine has appointed former US FDA senior adviser Dr Vicki Seyfert-Margolis to the role of chief of science and strategy.

Dr Seyfert-Margolis served as senior adviser, regulatory science and innovation at the US regulator, reporting directly to the commissioner.

During this time, she led the FDA's regulatory science and personalised medicine initiative, as well as strategies for promoting innovation in drug development.

Prior to her time with the FDA, Dr Seyfert-Margolis was chief science officer at the Immune Tolerance Network, a global research initiative to discover biomarkers for autoimmune disorders.

In her new role at Precision for Medicine, which provides research support to life science companies, Dr Syfert-Margolis will guide the company's scientific strategy and provide insight and support for its clients.

“Precision for Medicine shares my vision for the future of healthcare - one where the patient is not just the end user, but the focal point of all aspects of drug, diagnostic, and device development,” said Dr Seyfert-Margolis.

19th April 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics